Cytoplasmic fraction of Lactococcus lactis ssp. lactis induces apoptosis in SNU-1 stomach adenocarcinoma cells

BioFactors

Volumn 22, Issue 1-4, 2005, Pages 119-122

  Seo, Young Kim ^a   Ki, Won Lee ^a   Ji, Yeon Kim ^a   Hyong, Joo Lee ^a  

^a Seoul National University   (South Korea)

Author keywords

Apoptosis; Cytoplasmic fraction; Lactococcus lactis ssp. lactis; SNU 1 human stomach adenocarcinoma cell line

Indexed keywords

DNA FRAGMENT; PEPTIDOGLYCAN; PROBIOTIC AGENT; ANTINEOPLASTIC AGENT; CELL EXTRACT;

APOPTOSIS; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CHROMATIN CONDENSATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPLASM; DRUG ACTIVITY; DRUG DOSE REDUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; LACTOCOCCUS LACTIS; NONHUMAN; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; ADENOCARCINOMA; ARTICLE; CELL DIVISION; CHEMISTRY; CHROMATIN; DRUG EFFECT; ISOLATION AND PURIFICATION; STOMACH TUMOR; TUMOR CELL LINE;

LACTOCOCCUS LACTIS;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CELL EXTRACTS; CELL LINE, TUMOR; CHROMATIN; CYTOPLASM; HUMANS; LACTOCOCCUS LACTIS; STOMACH NEOPLASMS;

EID: 16244386854     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520220123     Document Type: Conference Paper

References (9)

1. G.A. Fichera and G. Giese, Non-immunologically-mediated cytotoxicity of Lactobacillus casei and its derivative peptidoglycan against tumor cell lines, Cancer Lett 85 (1994), 93-103.
2. S.E. Gilliland, Health and nutritional benefits from lactic acid bacteria, FEMS Microbiol Rev 7 (1990), 175-188.
3. J.Y. Kim, H.J. Woo, Y.S. Kim, K.H. Kim and H.J. Lee, Cell cycle dysregulation induced by cytoplasm of Lactococcus lactis ssp. lactis in SNUC2A, a colon cancer cell line, Nutr Cancer 46 (2003), 197-201.
4. J.Y. Kim, H.J. Woo, Y.S. Kim and H.J. Lee, Screening for antiproliferative effects of cellular components from lactic acid bacteria against human cancer cell lines, Biotechnol Lett 24 (2002), 1431-1436.
5. R. Lotan, Retinoids and apoptosis: implications for cancer chemoprevention and therapy, J Natl Cancer Inst 87 (1995), 1655-1657.
6. L. Di Marzio, F.P. Russo, S. D'Alo, L. Biordi, S. Ulisse, G. Amicosante, C. De Simone and M.G. Cifone, Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities, Nutr Cancer 40 (2001), 185-196.
7. G.H. McIntosh, P.J. Royle and M.J. Playne, A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats, Nutr Cancer 35 (1999), 153-159.
8. K. Sekine, T. Toida, M. Saito, M. Kuboyama, T. Kawashima and Y. Hashimoto, A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice, Cancer Res 45 (1985), 1300-1307.
9. J. Singh, A. Rivenson, M. Tomita, S. Shimamura, N. Ishibashi and B.S. Reddy, Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis, Carcinogenesis 18 (1997), 833-841.